Toll-like receptors expression and interferon-γ production by NK cells in human sepsis

Abstract

IntroductionDuring the course of infection, natural killer (NK) cells contribute to innate immunity by producing cytokines, particularly interferon-gamma (IFN-γ). In addition to their beneficial effects against infection, NK cells may play a detrimental role during systemic inflammation, causing lethality during sepsis. Little is known on the immune status of NK cells in patients with systemic inflammatory response syndrome (SIRS) or sepsis in terms of cell surface markers expression and IFN-γ production.MethodsWe investigated 27 sepsis patients and 11 patients with non-infectious SIRS. CD56bright and CD56dim NK cell subsets were identified by flow cytometry and Toll-like receptor (TLR)2, TLR4, TLR9, CX3CR1, CD16 and CD69 expression were analyzed, as well as ex vivo IFN-γ production by NK cells in whole blood samples.ResultsWe first showed that in NK cells from healthy controls, TLR2 and TLR4 expression is mainly intracellular, similarly to TLR9. Intracellular levels of TLR2 and TLR4, in both CD56bright and CD56dim NK cell subsets from sepsis patients, were increased compared to healthy subjects. In addition, the percentage of CD69+ cells was higher among NK cells of sepsis patients. No difference was observed for TLR9, CX3CR1, and CD16 expression. The ex vivo stimulation by TLR4 or TLR9 agonists, or whole bacteria in synergy with accessory cytokines (IL-15+IL-18), resulted in significant production of IFN-γ by NK cells of healthy controls. In contrast, for SIRS and sepsis patients this response was dramatically reduced.ConclusionsThis study reports for the first time an intracellular expression of TLR2 and TLR4 in human NK cells. Surface TLR4 expression allows discriminating sepsis and SIRS. Furthermore, during these pathologies, NK cells undergo an alteration of their immune status characterized by a profound reduction of their capacity to release IFN-γ.

Toll-like receptor-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells

“…Interestingly, the direct TLR4 stimulation of NK cells did not improve mortality in our model. These data are in line with two recent studies showing that NK cell reactivity to TLR4 agonist, was reduced in a murine model of sepsis-induced immunosuppression [18] and in humans suffering from sepsis or sterile systemic inflammation [32]. Finally, NK cell hyporeactivity to MPLA could be related to haemorrhage-induced decrease in intracellular TLR4.…”

Human CD56bright NK Cells: An Update

“…This CD56 bright enrichment responds to an increased apoptotic susceptibility of the CD56 dim counterpart (99). In a different scenario, but with a similar effect, patients with systemic inflammatory response syndrome or sepsis exhibit a low frequency of NK cells in peripheral blood and early NK cell activation during the development of sepsis (100,101). Ex vivo stimulation with accessory cytokines and TLR agonists results in a significantly impaired production of IFN-g from CD56…”

Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

“…These alterations appear to be associated with increased mortality in septic humans (57)(58)(59). Additionally, NK cell cytotoxic function is decreased (60).…”